Brian Carothers
Vice President & GM, Nucleic Acid Solutions, Agilent Technologies, Santa Clara, California, USA
False
The Future of Nucleic Acid Therapies
August 28, 2020
Medicines derived from genetic building blocks have the potential to transform patient care
1 min read
Newsletters
Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.
